Awakn Life Sciences Corp. has announced that it has signed a Memorandum of Understanding with the Multidisciplinary Association for Psychedelic Studies (MAPS) to explore a partnership to utilize MDMA-assisted therapy to treat Alcohol Use Disorder (AUD) in Europe.
Category Press Release
Published in BioSpace